EUVIMEDEUVIMED entdecken
Crossref

The protective effect of febuxostat in a rotenone mouse model of Parkinson’s disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways

Kholoud Mohamed Lasheen, Zeinab Mohammad, Nouran Ahmed, Ayman El-Sayed El-Sahar iD, Rabab Hamed Sayed iD

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgag009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Kholoud Mohamed Lasheen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Newgiza University, Cairo-Alexandria Desert Road, First 6th of October City, Giza 12563, Egypt. Hauptthemen laut MEDLINE: Febuxostat, Neuroprotective Agents, Parkinsonian Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In a rotenone-induced Parkinson’s disease (PD) mouse model, our study explored the neuroprotective effect of febuxostat, a non-purine selective xanthine oxidase inhibitor approved for gout management. In addition, this study explored the role of PI3K/Akt signaling and its downstream effectors in this neuroprotective activity.

Methods

Mice were administered rotenone (1.5 mg/kg, s.c., every 48 h) for 3 weeks to induce PD. Mice were treated with febuxostat (5 mg/kg, p.o.) daily 1 h before rotenone. Key findings Febuxostat improved motor function in open field, rotarod, and grip strength tests, attenuated body weight loss, preserved dopaminergic neurons, and restored TH levels in the striatum and substantia nigra (SN), elevated PI3K, p-Akt, and p-mTOR, increased the expression of Nrf2, lowered the expression of p-GSK-3β (Tyr216) and Bax/Bcl2 ratio, replenished GSH and HO-1 levels, and reduced MDA, TNF-α, and NF-κB levels in the striatum of rotenone-intoxicated mice.

Conclusions

This study revealed that febuxostat provides neuroprotective benefits in a rotenone-induced PD model in mice. These beneficial effects are likely due to inhibition of oxidative stress, inflammation, and apoptosis. Additionally, the observed antioxidant, anti-inflammatory, and anti-apoptotic effects of febuxostat may be related to its ability to activate PI3K/Akt/mTOR cascade, diminish p-GSK-3β expression, and up-regulate Nrf2/HO-1 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FebuxostatNeuroprotective AgentsParkinsonian DisordersAnimalsNF-E2-Related Factor 2RotenoneProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesMaleMiceHeme Oxygenase-1Glycogen Synthase Kinase 3 betaDisease Models, AnimalPhosphatidylinositol 3-KinasesOxidative StressMembrane Proteins

Stichwörter der Autor:innen

Nrf2PI3K/AktParkinson’s diseasefebuxostatmicerotenone

Substanzen

NF-E2-Related Factor 2RotenoneProto-Oncogene Proteins c-aktFebuxostatTOR Serine-Threonine KinasesNeuroprotective AgentsHeme Oxygenase-1Glycogen Synthase Kinase 3 betaNfe2l2 protein, mousePhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • School of Pharmacy, Newgiza University, Cairo-Alexandria Desert Road, First 6th of October City, Giza 12563, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr Al-Ainy Street, El-Manial District, Cairo 11562, Egypt.
  • Clinical Pharmacy Department, School of Pharmacy, Newgiza University, Cairo-Alexandria Desert Road, First 6th of October City, Giza 12563, Egypt.

ORCID-Profile: Ayman El-Sayed El-Sahar, Rabab Hamed Sayed

Zitieren

APA

Lasheen, K. M., Mohammad, Z., Ahmed, N., El-Sahar, A. E., & Sayed, R. H. (2026). The protective effect of febuxostat in a rotenone mouse model of Parkinson’s disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag009

Vancouver

Lasheen KM, Mohammad Z, Ahmed N, El-Sahar AE, Sayed RH. The protective effect of febuxostat in a rotenone mouse model of Parkinson’s disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgag009

BibTeX
@article{Lasheen2026,
  author = {Lasheen, Kholoud Mohamed and Mohammad, Zeinab and Ahmed, Nouran and El-Sahar, Ayman El-Sayed and Sayed, Rabab Hamed},
  title = {The protective effect of febuxostat in a rotenone mouse model of Parkinson’s disease: the interplay between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 signaling pathways},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgag009}
}
Kostenlos starten →